Health & Medicine
FDA-Approved Diabetes Medication Shows Potential to Lower Heart Attack and Stroke Risks: Research
A recent study reveals that Sotagliflozin, an FDA-approved medication for type 2 diabetes, shows significant potential in reducing the risks of heart attacks and strokes, suggesting a dual benefit…